Mora chile
Selected indexed studies
- Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. (JAMA, 2019) [PMID:30772908]
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. (Lancet, 2019) [PMID:31189511]
- Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial. (JAMA, 2025) [PMID:41159835]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. (2019) pubmed
- Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial. (2019) pubmed
- Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial. (2025) pubmed
- Consensus-Based Management Protocol (CREVICE Protocol) for the Treatment of Severe Traumatic Brain Injury Based on Imaging and Clinical Examination for Use When Intracranial Pressure Monitoring Is Not Employed. (2020) pubmed
- The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. (2023) pubmed
- Grazing and ecosystem service delivery in global drylands. (2022) pubmed
- Unforeseen plant phenotypic diversity in a dry and grazed world. (2024) pubmed
- Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. (2019) pubmed
- Hotspots of biogeochemical activity linked to aridity and plant traits across global drylands. (2024) pubmed
- COVID-19 associated cutaneous polyarteritis nodosa. (2024) pubmed